CAPLIN POINT LABORATORIES LTD. - 524742 - Closure of Trading Window
Trading Window Closure intimation pertaining to Q2 results28-09-2023
28-09-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Allotment of 1,000 securities pursuant to ESOP28-09-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
This is to inform mentioned share certificates has been reported as lost by shareholders of the company.26-09-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Voting Results and Scrutinizer Report for the 32nd AGM of the Company22-09-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 32nd Annual General Meeting of the Company held on 21st September 202321-09-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Change in Directorate
Re-appointment of Dr.C K Gariyali (DIN 08711546) as an Independent Director of the company.21-09-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
Intimation under Regulation 30 of SEBI Regulations 2015 - Appointment of Statutory Auditors of the Company.21-09-2023
Caplin Point subsidiary gets USFDA approval for Norepinephrine Bitartrate injection
Earlier this month, Caplin Steriles received an Establishment Inspection Report from USFDA for one of its unit20-09-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release (Revised)
Press Release regarding grant of final approval by the USFDA for the ANDA Norepinephrine Bitartrate Injection USO to our subsidiary Caplin Steriles Limited.20-09-2023
CAPLIN POINT LABORATORIES LTD. - 524742 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release regarding grant of final approval by the United States Food and Drug Administration (USFDA) for the Abbreviated New Drug Application (ANDA) Norepinephrine Bitartrate Injection USP to our subsidiary Caplin Steriles Limited.20-09-2023